Stem cells have an innate property that attracts them to inflammation in the body. Studies have shown that stem cells can regenerate damaged or diseased tissues, reduce inflammation and modulate the immune system promoting better health and quality of life.
Stem cells for COPD have the unique ability to change into any type of cell in the body, called ‘differentiation’. They can be administered intravenously and find damaged tissues around organs. When used in regards to COPD patients, stem cell therapy for COPD has the ability to repair damaged lung tissue to combat emphysema, and have natural anti-inflammatory properties which can clear airways for those with chronic bronchitis. While this treatment is still in the early stages of development, studies have already been completed to quantify the effects of stem cell therapy.
According to a report done by the Lung Institute called ‘Autologous Stem Cell Therapy and its Effects on COPD’, over 82% of patients that attempted stem cell treatment had noticeable improvements in their quality of life after their therapies. Many of these patients reported increased lung capacity and ability to walk following treatment. This positioned stem cells as one of the best viable options for current patients with COPD. While stem cell treatment for COPD has not shown the ability to cure the condition, its ability to repair damaged tissue and relatively invasive nature make it an attractive alternative to patients. This path becomes even more desirable when considering the current treatment protocols requiring use of ventilators or even total lung transplants, which are rare and extremely expensive.